A PCR-based technique was used to generate a large pool of random sequence double-stranded DNAs. Four DNA sequences that selectively bound in vitro to a mutant p53 143A protein, synthesized in baculovirus infected cells, were characterized. The four DNA sequences all approximated the known consensus sequence for wild-type p53. Wild-type p53 also bound the four DNA sequences. Two other mutant p53 proteins (His 175 or Trp 248) did not bind. The ability of mutant p53 143A protein to bind to DNA is totally dependent on the irt vitro system used to synthesize the p53 protein. Rabbit reticulocyte lysate (RRL) or wheat germ lysate (WGL) produced mutant p53 143A is unable to bind to DNA but does bind to a known protein partner, hdm2, thus these activities can be uncoupled.

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.10.5.1035DOI Listing

Publication Analysis

Top Keywords

mutant p53
24
produced mutant
12
dna sequences
12
p53 143a
12
p53
9
wgl produced
8
p53 protein
8
143a protein
8
wild-type p53
8
bind dna
8

Similar Publications

Rituximab combined with systemic chemotherapy significantly improves the rate of complete response in B-cell lymphomas. However, acquired rituximab resistance develops in most patients leading to relapse. The mechanisms underlying rituximab resistance are not well-understood.

View Article and Find Full Text PDF

Targeting mutant p53: Evaluation of novel anti-p53 monoclonal antibodies as diagnostic tools.

Sci Rep

January 2025

Department of Microbiology, Tumor and Cell Biology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.

About 50% of all cancers carry a mutation in p53 that impairs its tumor suppressor function. The p53 missense mutation p53 (p53 in mice) is a hotspot mutation in various cancer types. Therefore, monoclonal antibodies selectively targeting clinically relevant mutations like p53 could prove immensely value.

View Article and Find Full Text PDF

Molecular Mechanisms of Synergistic Effect of PRIMA-1 and Oxaliplatin in Colorectal Cancer With Different p53 Status.

Cancer Med

January 2025

Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, People's Republic of China.

Background: The toxicity and drug resistance associated with oxaliplatin (L-OHP) limit its long-term use for colorectal cancer (CRC) patients. p53 mutation is a common genetic trait of CRC. PRIMA-1 (APR-246, eprenetapopt) restores the DNA-binding capacity of different mutant P53 proteins.

View Article and Find Full Text PDF

Actinic keratosis with severe dysplasia and Bowen disease represent distinct pathways of intraepidermal squamous neoplasia: an immunohistochemical study.

Pathology

December 2024

Department of Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Perth, WA, Australia; School of Medicine, Notre Dame University, Fremantle, WA, Australia. Electronic address:

Intraepidermal squamous neoplasia is a precursor to invasive cutaneous squamous cell carcinoma. The most common type of intraepidermal squamous neoplasia is actinic keratosis (AK), although there is compelling clinicopathological evidence of a second distinct pattern of squamous dysplasia termed Bowen disease (BD). The distinction between these pathways of dysplasia has been inconsistently delineated in the literature.

View Article and Find Full Text PDF

Beta papillomaviruses: From foe to friend in skin cancer immunity.

Cancer Cell

December 2024

Pre-Cancer Immunology Laboratory, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London WC1E 6BT, UK; Cancer Research UK Lung Cancer Centre of Excellence. Electronic address:

In this issue of Cancer Cell, Son et al. highlight an unexpected role for skin β-papillomaviruses in the protection against skin carcinogenesis. T cell immunity to skin papillomaviruses blocks the expansion of p53 mutant clones in ultraviolet (UV) radiation-damaged skin, preventing the development of skin cancer.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!